CHE Chemed Corporation

548.59USD-0.50%Mkt Cap: 7.11B USDP/E: 26.27

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United …

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap7.11B USD
Enterprise Value7.49B USD
Revenue (TTM)2.66B USD
Gross Profit823.18M USD
Net Income (TTM)265.24M USD
Revenue/Share197.53 USD
Last Price548.59 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees15.8K
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)26.27
P/E (Forward)19.70
PEG1.96
EV/EBITDA16.85
EV/Revenue2.81
P/S2.67
P/B8.25
EPS (TTM)20.88 USD
EPS (Forward)27.85 USD
52W Range
365.2193% of range562.24
52W High562.24 USD
52W Low365.21 USD
Profitability
Gross Margin32.54%
Oper. Margin14.32%
EBITDA Margin16.70%
Profit Margin10.48%
ROE27.08%
ROA17.24%
ROIC24.25%
ROCE27.27%
Growth
Revenue Growth10.60%
Earnings Growth22.20%
Cash Flow & Leverage
Operating CF388.27M USD
CapEx (TTM)62.80M USD
FCF Margin9.98%
FCF Yield3.73%
Net Debt343.77M USD
Net Debt/EBITDA0.77
Net Debt/FCF1.29
Balance Sheet
Debt/Equity0.15
Current Ratio1.10
Quick Ratio0.92
Book Value/Sh66.47 USD
Cash/Share3.74 USD
Dividends
Fwd Div Rate2.80 USD
Trail. Div Rate2.50 USD
Div. Yield0.51%
5Y Avg Yield0.33%
Payout Ratio11.97%
Ex-Div DateNov 16, 2026
Pay DateDec 4, 2026
Splits
Last Split2:1
Split DateMay 12, 2005
Analyst Consensus
Rating1.8 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)617.00 USD
Upside (mean)+12.5%
Target Range580.00 USD – 675.00 USD
580.00+12.5% to mean675.00
# Analysts5
Ownership
Shares Out.12.96M
Float11.78M
Insiders1.90%
Institutions104.21%
Short Interest
Short Ratio5.3d
Short % Float7.25%
Short % Out.6.14%
Shares Short795.99K
Short (prev mo.)596.75K
Technical
SMA 50518.79 (+5.7%)
SMA 200469.32 (+16.9%)
Beta0.49
S&P 52W Chg12.00%
Avg Vol (30d)147.64K
Avg Vol (10d)142.73K
Technical Indicators
RSI (14)59.4
MACD8.5749
MACD Signal8.4797
MACD Hist.+0.0953
BB Upper563.74 USD
BB Middle539.65 USD
BB Lower515.56 USD
BB Width8.93%
ATR (14)13.31 USD
Vol Ratio (20d)0.82x

About Chemed (NYSE: CHE)

›

Chemed (NYSE: CHE) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 15,811 employees.

The shares were at 548.59 USD on 20 November 2026, up 27.0% over 52 weeks. Its 52-week range is 365.21 USD to 562.24 USD: the price is 2.4% below the high and 50.2% above the low.

At a market capitalisation of 7.11B USD, it trades at 26.3 times trailing earnings and 19.7 times forward earnings. The median trailing P/E of its 18 largest Medical Care Facilities peers is 22.1, a premium of 19% for CHE. It pays a dividend yielding 0.51% (it pays out 12% of its earnings), against a median of 0.84% among the dividend payers in that peer group.

Chemed reports return on equity of 27.1%, an operating margin of 14.3% and revenue up 10.6% year over year.

Its debt exceeds its cash by 343.77M USD, a debt-to-equity ratio of 0.15. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. 5 analysts cover the stock, with an average rating of Buy; their mean price target of 617.00 USD is 12.5% above the current price. The next earnings report is expected on 24 February 2027.